Frontiers in Oncology Seminars
Oncologic Anthropology- Genetics/Genomics and Triple Negative Breast Cancer Associated with African Ancestry
May 17, 2022
Lisa Newman, MD, MPH, is a surgical oncologist and chief of breast surgery at the Weill Cornell Medical Center. Dr. Newman’s primary research is focused on race/ethnicity-related variation in breast cancer risk and outcome, the evaluation and management of high-risk patients; broadened applications for neoadjuvant chemotherapy, and special surgical techniques such as the skin-sparing mastectomy and lymphatic mapping/sentinel lymph node biopsy. She currently serves as Chief National Medical Advisor for the Sisters Network, Inc., a national African American breast cancer survivors support organization.
She oversees an international breast cancer research and training program involving a network of physicians and facilities in Ghana, Ethiopia, Nigeria, Uganda, Mexico, and the Caribbean. This program is focused on the study of triple negative breast cancer in women with African ancestry. Dr. Newman has been appointed to multiple national and regional leadership positions, including the CDC’s Advisory Committee on Breast Cancer in Young Women; the NIH’s Clinical Trials Advisory Committee and the Advisory Council to the National Institute of Minority Health and Disparities. Dr. Newman is chair of the AACR Regional Advisory Group on Africa, and in October 2019 she was appointed Vice President for the American College of Surgeons.